Headline March 16, 2018/ ''' *HISTORY* -DATA- *HUNTERS* '''

''' *HISTORY* -DATA- *HUNTERS* '''

IN THE BEAUTIFUL YEARS AHEAD - every single company in the world, - one way or the other - will be after your records, your data.

WHO'S data is it anyway? Why, the students of the world, of course!

On *!WOW! Confidential* - you have to guard everything with your life. Students data is a sacred,  sacrosanct, record.   

*It is for your elected representatives to turn it to Oil and Gold*.

Learning from the experience of millions of patients provides, provides granularity and is especially important in a disease like cancer when doctors want to know-

If there is greater benefit from using a certain drug in patients with highly specific tumour characteristics.

In this case of  Flatiron deal, Roche is acquiring a firm working with 265 US community cancer clinics and six major research centres, making it a leading curator of oncology evidence.

Roche which already owns 12.6 percent of Flatiron, will pay $1.9 billion for the rest.

*But interest  in such real-world data goes far beyond cancer*. 

THE WORLD STUDENTS SOCIETY - most lovingly and respectfully called !WOW! - the entire world over, is totally owned by-

*Every single student in the world*  : OneShare-Piece-Peace. This fact is planned and supposed to be the crowning achievement of you all.

ALL THE WORLD'S major drug companies now have departments focused on the use of  real-world- data across multiple diseases and-

Several have completed scientific studies using the information to delve into key areas addressed by their drugs.

They include diabetes studies by AstraZeneca and Sanoli, joint research by Pfizer and Bristol Myers Squibb into stroke prevention and a Takeda Pharmaceutical project in bowel disease.

''It's getting more expensive to do traditional clinical trial research, so industry is looking at ways it can achieve similar goals using routinely collected data,'' said Paul Taylor, a health informatics  expert at University College London.

 ''The thing that has made all this possible is the increasing digitisation of health records.''

Significantly, the world's regulators are taking notice.

US Food and Drug Administration [FDA], Commissioner Scott Gottlieb -to evaluate the gatekeeper to the world's biggest pharmaceutical market - believes more widespread use of real-world evidence [RWE] could cut drug development costs and help doctors make better medical choices.

Under the 21st Century Gures Act, the FDA has been directed to evaluate the expanded use of RWE.

''As the breadth of and reliability of RWE  increases, so do opportunities for FDA to also make use this information,'' Gottlieb said in a speech last September.

The  European Medicine Agency, too, is studying ways to use RWE in its decision making.

*Who's Data is it anyway?*

But the growth of real-world evidence also raises questions about data access and patient privacy, as Britain's Health Service [NHS]  -a unique comprehensive source  of  healthcare data   -has found to its cost.

An ambitious scheme to pool anonymised  NHS  patient data for both academic and commercial use had to be scrapped in 2016 after protests from both patients and doctors.

And last year a  British hospital  trust was rapped by the Information Commissioner's Office  for misusing data, after it passed on-

Personal information of around 1.6 million patients to artificial-intelligence firm Google DeepMind.

Sam Smith, a campaigner for medical data privacy at Britain's MedConfidential, is concerned drugmakers' RWE studies are just a cover for marketing.

''How much of this is really for scientific discovery and how much is it about boosting profits by getting one product used instead of another?''

Some academics also worry RWE studies could be susceptible to 'data dredging', where multiple analyses are conducted until one gives the hoped-for-result.

AstraZeneeca's head of innovative medicines Mene Pangalos, whose company has struck  several deals with tech-start-ups and patient groups to gather real-world data, acknowledges-

*Ensuring privacy and scientific rigour is a challenge*.

''It's a real problem but I don't think it's insurmountable.'' he said.     

With  respectful dedication   to the Students, Professors and Teachers of the world. See Ya all on !WOW! - the World Students Society and.......... Twitter-!E-WOW! - the Ecosystem 2011:

''' World Winsome '''

Good Night and God Bless

SAM Daily Times - the Voice of the Voiceless